CombiGene AB (publ) (the “Company”) held an extraordinary general meeting (“EGM”) on 10 December 2024 via digital connection. Below is a summary of the decisions passed at the EGM.
Amendment of the Articles of Association
The EGM resolved, in accordance with the shareholder Strategic Partner A/S’s proposal, to amend the Articles of Association. The amendment was made in order to expand the scope of the business objectives, whereby the Company shall also have the opportunity to enter into strategic collaborations with other companies in other industries.
Board of Directors
The EGM resolved, in accordance with the shareholder Strategic Partner A/S’s proposal, that the Board of Directors shall consist of three ordinary Board members and one deputy Board member. Luca Di Stefano and Jakob Bendtsen were elected, and Marcus Isaksson was re-elected, as ordinary Board members and Lars Thunberg was elected as new deputy Board member. Furthermore, Luca Di Stefano was elected as Chairman of the Board of Directors.
